Local corticosteroid treatment of eyelid and orbital xanthogranuloma

Victor M. Elner, Roni Mintz, Hakan Demirci, Adam S. Hassan, Steven E. Feldon, Malcolm R. Ing, Ralph C. Eagle, David Wilson, Evelyn A. Paysse, Victor M. Elner

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Purpose: To demonstrate the efficacy of local corticosteroid therapy for the treatment of eyelid and orbital xanthogranuloma in adults. Methods: We performed a retrospective chart review of six patients receiving local triamcinolone acetonide (40 mg/mL) injections for the treatment of eyelid and orbital xanthogranuloma at the University of Michigan. All patients underwent diagnostic biopsy prior to treatment. The effects of this therapy on symptoms and signs of the disease were assessed. Results: All six patients complained of eyelid swelling or nodularity, and five had yellow discoloration of their eyelids. All lesions involved the eyelids and anterior orbit, and five were present bilaterally. Biopsy revealed necrobiotic xanthogranuloma in four patients and adult-onset xanthogranuloma in two patients. Triamcinolone acetonide was administered intralesionally as series of two to 25 injections. Local control was obtained in all six cases, with the reduction of symptoms and signs of the disease in five cases. Two patients with necrobiotic xanthogranuloma developed non-Hodgkin's lymphoma. Average follow-up of patients whose treatment was not truncated by systemic chemotherapy was 52 months (range, 30 to 86 months). No complications occurred as a result of this treatment. Conclusion: Intralesional injection of triamcinolone acetonide is an effective, safe treatment for orbital xanthogranuloma in adults. This modality avoids the side effects associated with systemic corticosteroid or cytotoxic agent therapy.

Original languageEnglish (US)
Pages (from-to)69-74
Number of pages6
JournalTransactions of the American Ophthalmological Society
Volume103
StatePublished - 2005
Externally publishedYes

Fingerprint

Eyelids
Adrenal Cortex Hormones
Triamcinolone Acetonide
Necrobiotic Xanthogranuloma
Therapeutics
Signs and Symptoms
Intralesional Injections
Biopsy
Injections
Cytotoxins
Orbit
Non-Hodgkin's Lymphoma
Drug Therapy

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Elner, V. M., Mintz, R., Demirci, H., Hassan, A. S., Feldon, S. E., Ing, M. R., ... Elner, V. M. (2005). Local corticosteroid treatment of eyelid and orbital xanthogranuloma. Transactions of the American Ophthalmological Society, 103, 69-74.

Local corticosteroid treatment of eyelid and orbital xanthogranuloma. / Elner, Victor M.; Mintz, Roni; Demirci, Hakan; Hassan, Adam S.; Feldon, Steven E.; Ing, Malcolm R.; Eagle, Ralph C.; Wilson, David; Paysse, Evelyn A.; Elner, Victor M.

In: Transactions of the American Ophthalmological Society, Vol. 103, 2005, p. 69-74.

Research output: Contribution to journalArticle

Elner, VM, Mintz, R, Demirci, H, Hassan, AS, Feldon, SE, Ing, MR, Eagle, RC, Wilson, D, Paysse, EA & Elner, VM 2005, 'Local corticosteroid treatment of eyelid and orbital xanthogranuloma', Transactions of the American Ophthalmological Society, vol. 103, pp. 69-74.
Elner VM, Mintz R, Demirci H, Hassan AS, Feldon SE, Ing MR et al. Local corticosteroid treatment of eyelid and orbital xanthogranuloma. Transactions of the American Ophthalmological Society. 2005;103:69-74.
Elner, Victor M. ; Mintz, Roni ; Demirci, Hakan ; Hassan, Adam S. ; Feldon, Steven E. ; Ing, Malcolm R. ; Eagle, Ralph C. ; Wilson, David ; Paysse, Evelyn A. ; Elner, Victor M. / Local corticosteroid treatment of eyelid and orbital xanthogranuloma. In: Transactions of the American Ophthalmological Society. 2005 ; Vol. 103. pp. 69-74.
@article{d08fab14a1ff40d8a462d39dfcfb1159,
title = "Local corticosteroid treatment of eyelid and orbital xanthogranuloma",
abstract = "Purpose: To demonstrate the efficacy of local corticosteroid therapy for the treatment of eyelid and orbital xanthogranuloma in adults. Methods: We performed a retrospective chart review of six patients receiving local triamcinolone acetonide (40 mg/mL) injections for the treatment of eyelid and orbital xanthogranuloma at the University of Michigan. All patients underwent diagnostic biopsy prior to treatment. The effects of this therapy on symptoms and signs of the disease were assessed. Results: All six patients complained of eyelid swelling or nodularity, and five had yellow discoloration of their eyelids. All lesions involved the eyelids and anterior orbit, and five were present bilaterally. Biopsy revealed necrobiotic xanthogranuloma in four patients and adult-onset xanthogranuloma in two patients. Triamcinolone acetonide was administered intralesionally as series of two to 25 injections. Local control was obtained in all six cases, with the reduction of symptoms and signs of the disease in five cases. Two patients with necrobiotic xanthogranuloma developed non-Hodgkin's lymphoma. Average follow-up of patients whose treatment was not truncated by systemic chemotherapy was 52 months (range, 30 to 86 months). No complications occurred as a result of this treatment. Conclusion: Intralesional injection of triamcinolone acetonide is an effective, safe treatment for orbital xanthogranuloma in adults. This modality avoids the side effects associated with systemic corticosteroid or cytotoxic agent therapy.",
author = "Elner, {Victor M.} and Roni Mintz and Hakan Demirci and Hassan, {Adam S.} and Feldon, {Steven E.} and Ing, {Malcolm R.} and Eagle, {Ralph C.} and David Wilson and Paysse, {Evelyn A.} and Elner, {Victor M.}",
year = "2005",
language = "English (US)",
volume = "103",
pages = "69--74",
journal = "Transactions of the American Ophthalmological Society",
issn = "0065-9533",
publisher = "American Ophthalmological Society",

}

TY - JOUR

T1 - Local corticosteroid treatment of eyelid and orbital xanthogranuloma

AU - Elner, Victor M.

AU - Mintz, Roni

AU - Demirci, Hakan

AU - Hassan, Adam S.

AU - Feldon, Steven E.

AU - Ing, Malcolm R.

AU - Eagle, Ralph C.

AU - Wilson, David

AU - Paysse, Evelyn A.

AU - Elner, Victor M.

PY - 2005

Y1 - 2005

N2 - Purpose: To demonstrate the efficacy of local corticosteroid therapy for the treatment of eyelid and orbital xanthogranuloma in adults. Methods: We performed a retrospective chart review of six patients receiving local triamcinolone acetonide (40 mg/mL) injections for the treatment of eyelid and orbital xanthogranuloma at the University of Michigan. All patients underwent diagnostic biopsy prior to treatment. The effects of this therapy on symptoms and signs of the disease were assessed. Results: All six patients complained of eyelid swelling or nodularity, and five had yellow discoloration of their eyelids. All lesions involved the eyelids and anterior orbit, and five were present bilaterally. Biopsy revealed necrobiotic xanthogranuloma in four patients and adult-onset xanthogranuloma in two patients. Triamcinolone acetonide was administered intralesionally as series of two to 25 injections. Local control was obtained in all six cases, with the reduction of symptoms and signs of the disease in five cases. Two patients with necrobiotic xanthogranuloma developed non-Hodgkin's lymphoma. Average follow-up of patients whose treatment was not truncated by systemic chemotherapy was 52 months (range, 30 to 86 months). No complications occurred as a result of this treatment. Conclusion: Intralesional injection of triamcinolone acetonide is an effective, safe treatment for orbital xanthogranuloma in adults. This modality avoids the side effects associated with systemic corticosteroid or cytotoxic agent therapy.

AB - Purpose: To demonstrate the efficacy of local corticosteroid therapy for the treatment of eyelid and orbital xanthogranuloma in adults. Methods: We performed a retrospective chart review of six patients receiving local triamcinolone acetonide (40 mg/mL) injections for the treatment of eyelid and orbital xanthogranuloma at the University of Michigan. All patients underwent diagnostic biopsy prior to treatment. The effects of this therapy on symptoms and signs of the disease were assessed. Results: All six patients complained of eyelid swelling or nodularity, and five had yellow discoloration of their eyelids. All lesions involved the eyelids and anterior orbit, and five were present bilaterally. Biopsy revealed necrobiotic xanthogranuloma in four patients and adult-onset xanthogranuloma in two patients. Triamcinolone acetonide was administered intralesionally as series of two to 25 injections. Local control was obtained in all six cases, with the reduction of symptoms and signs of the disease in five cases. Two patients with necrobiotic xanthogranuloma developed non-Hodgkin's lymphoma. Average follow-up of patients whose treatment was not truncated by systemic chemotherapy was 52 months (range, 30 to 86 months). No complications occurred as a result of this treatment. Conclusion: Intralesional injection of triamcinolone acetonide is an effective, safe treatment for orbital xanthogranuloma in adults. This modality avoids the side effects associated with systemic corticosteroid or cytotoxic agent therapy.

UR - http://www.scopus.com/inward/record.url?scp=29944432970&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29944432970&partnerID=8YFLogxK

M3 - Article

C2 - 17057789

AN - SCOPUS:29944432970

VL - 103

SP - 69

EP - 74

JO - Transactions of the American Ophthalmological Society

JF - Transactions of the American Ophthalmological Society

SN - 0065-9533

ER -